Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TCERG1 pseudogene 2 (TCERG1P2) is a genomic pseudogene resembling TCERG1, a protein involved in regulation of transcription elongation and alternative splicing[2][3]. Unlike the functional TCERG1, TCERG1P2 is not believed to encode a functional protein and has no demonstrated role in cellular biology or disease. Most scientific and medical resources refer to TCERG1 for molecular function, therapeutic relevance, and published disease links, but TCERG1P2 itself remains unmapped as a target for therapies or diagnostics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TCERG1 pseudogene 2 (TCERG1P2).